Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma

Compared with other epithelial ovarian carcinoma subtypes, ovarian clear cell carcinoma (OCCC) has been recognized to show chemoresistance. Therefore, new treatment modalities are required for patients with OCCC that is refractory to chemotherapy. The carcinoembryonic antigen glypican-3 (GPC3) is ex...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncoimmunology
Hauptverfasser: Suzuki, Shiro, Sakata, Jun, Utsumi, Fumi, Sekiya, Ryuichiro, Kajiyama, Hiroaki, Shibata, Kiyosumi, Kikkawa, Fumitaka, Nakatsura, Tetsuya
Format: Artigo
Sprache:Inglês
Veröffentlicht: Taylor & Francis 2016
Schlagworte:
Original Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC5139642/
https://ncbi.nlm.nih.gov/pubmed/27999758
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2016.1238542
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge